References

Hallmarks of cancer: the next generation

10.1016/j.cell.2011.02.013 · 2011 · External reference

Understanding the Warburg effect: the metabolic requirements of cell proliferation

10.1126/science.1160809 · 2009 · External reference

Lipid metabolism in cancer cells under metabolic stress

10.1038/s41416-019-0451-4 · 2019 · External reference

Lipid metabolism in cancer cells: its role in hepatocellular carcinoma progression and therapeutic resistance

10.1097/hc9.0000000000000837 · 2025 · External reference

Lipid metabolism and resistance to anticancer treatment

2020 · External reference

How cancer cells remodel lipid metabolism: strategies targeting transcription factors

10.1186/s12944-021-01593-8 · 2021 · External reference

Lipids and genes: regulatory roles of lipids in RNA expression

10.1002/ctm2.863 · 2022 · External reference

Lipid metabolism and lipidomics applications in cancer research

10.1007/978-981-33-6785-2_1 · 2021 · External reference

Hepatocellular carcinoma: a review

10.2147/jhc.s61146 · 2016 · External reference

Progression of chronic liver disease to hepatocellular carcinoma: implications for surveillance and management

10.1038/s44276-024-00050-0 · 2024 · External reference

Lipid alterations in chronic liver disease and liver cancer

2022 · External reference

Protective effect of alpha-mangostin on thioacetamide-induced liver fibrosis in rats as revealed by morpho-functional analysis

2019 · External reference

Molecular changes following induction of hepatocellular carcinoma by diethylnitrosamine and thioacetamide, and subsequent treatment with dioscorea membranacea extract

10.7150/ijms.72987 · 2022 · External reference

Anti-angiogenic and anti-proliferative effects of Benja-ummarit extract in rats with hepatocellular carcinoma

2020 · External reference

An integrated computational, in vitro and metabolomics approach to the discovery of novel aromatase inhibitors with anti-breast cancer activities

10.1038/s41598-025-24086-5 · 2025 · External reference

MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation

10.1093/nar/gkae253 · 2024 · External reference

Sustained epigenetic drug delivery depletes cholesterol-sphingomyelin rafts from resistant breast cancer cells, influencing biophysical characteristics of membrane lipids

10.1021/acs.langmuir.5b02601 · 2015 · External reference

Liver histology: diagnostic and prognostic features

10.1016/j.cld.2019.09.004 · 2020 · External reference

Histopathological evaluation of liver fibrosis and cirrhosis regression

10.3350/cmh.2017.0078 · 2017 · External reference

Liver pathology: cirrhosis, hepatitis, and primary liver tumors. Update and diagnostic problems

10.1038/modpathol.3880119 · 2000 · External reference

Perinodular arteriolar plexus in liver cirrhosis. Scanning electron microscopy of microvascular casts

10.1111/j.1600-0676.1984.tb00907.x · 1984 · External reference

Collagen arrangement in space of Disse correlates with fluid flow in normal and cirrhotic rat livers

10.1002/jemt.22460 · 2015 · External reference

Histopathology of hepatocellular carcinoma

10.3748/wjg.v20.i43.15955 · 2014 · External reference

Fibrosis-dependent mechanisms of hepatocarcinogenesis

10.1002/hep.25670 · 2012 · External reference

PNPLA3 genotype, arachidonic acid intake, and unsaturated fat intake influences liver fibrosis in hispanic youth with obesity

10.3390/nu13051621 · 2021 · External reference

Sandrin L. Liver stiffness: a novel parameter for the diagnosis of liver disease

2010 · External reference

Control of oxidative stress in hepatocellular carcinoma: helpful or harmful?

10.4254/wjh.v7.i7.968 · 2015 · External reference

The role of oxidative stress in tumorigenesis and progression

10.3390/cells13050441 · 2024 · External reference

Altered metabolism in cancer: insights into energy pathways and therapeutic targets

10.1186/s12943-024-02119-3 · 2024 · External reference

Targeted inhibition of ACLY expression to reverse the resistance of sorafenib in hepatocellular carcinoma

10.7150/jca.52778 · 2022 · External reference

Accumulation of cholesterol, triglycerides and ceramides in hepatocellular carcinomas of diethylnitrosamine injected mice

10.1186/s12944-021-01567-w · 2021 · External reference

Regulation of the specific release of arachidonic acid by cytosolic phospholipase A2

10.1016/j.plefa.2003.12.012 · 2004 · External reference

An updated review of lysophosphatidylcholine metabolism in human diseases

10.3390/ijms20051149 · 2019 · External reference

Breaking down tumor drug resistance: the link between cell membrane changes and treatment efficacy

10.2478/abmj-2023-0003 · 2023 · External reference

The interplay between membrane viscosity and ligand-binding receptor kinetics in lipid bilayers

10.1007/s11012-024-01779-1 · 2024 · External reference

Cytosolic phospholipase A2: targeting cancer through the tumor vasculature

10.1158/1078-0432.ccr-08-1905 · 2009 · External reference

The lipoprotein-associated phospholipase A2 inhibitor Darapladib sensitises cancer cells to ferroptosis by remodelling lipid metabolism

10.1038/s41467-023-41462-9 · 2023 · External reference

Understanding sorafenib-induced ferroptosis and resistance mechanisms: implications for cancer therapy

10.1016/j.ejphar.2023.175913 · 2023 · External reference

Polyunsaturated fatty acids drive lipid peroxidation during ferroptosis

10.3390/cells12050804 · 2023 · External reference

Cytosolic phospholipase A₂: physiological function and role in disease

10.1194/jlr.r057588 · 2015 · External reference

Aberrant lipid metabolism in hepatocellular carcinoma revealed by liver lipidomics

10.3390/ijms18122550 · 2017 · External reference

LPCAT1 overexpression promotes the progression of hepatocellular carcinoma

10.1186/s12935-021-02130-4 · 2021 · External reference

Comparison of hepatic and serum lipid signatures in hepatocellular carcinoma patients leads to the discovery of diagnostic and prognostic biomarkers

10.18632/oncotarget.23494 · 2018 · External reference

Decreased lncRNA HNF4A-AS1 facilitates resistance to sorafenib-induced ferroptosis of hepatocellular carcinoma by reprogramming lipid metabolism

10.7150/thno.99197 · 2024 · External reference